Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients

SARI, ALPER; Guven, Denizcan; ARMAĞAN, BERKAN; ERDEN, ABDULSAMET; KALYONCU, UMUT; KARADAĞ, ÖMER; APRAŞ BİLGEN, ŞAZİYE; Ertenli, Ihsan; KİRAZ, SEDAT; AKDOĞAN, ALİ

doi:10.1097/rhu.0000000000000584

Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients

Atıf İçin Kopyala

SARI A., Guven D., ARMAĞAN B., ERDEN A., KALYONCU U., KARADAĞ Ö., ...Daha Fazla

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, cilt.23, sa.8, ss.411-415, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 23 Sayı: 8
Basım Tarihi: 2017
Doi Numarası: 10.1097/rhu.0000000000000584
Dergi Adı: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.411-415
Anahtar Kelimeler: interstitial lung disease, rituximab, systemic sclerosis, MYCOPHENOLATE-MOFETIL, EUSTAR DATABASE, TRIAL, CYCLOPHOSPHAMIDE, SAFETY, SKIN, TRANSPLANTATION, EFFICACY, DEATH
Hacettepe Üniversitesi Adresli: Evet

Özet

Objectives The objective of this study was to report the experience with rituximab treatment in a case series of patients with long-standing systemic sclerosis-associated interstitial lung disease (SSc-ILD).